Glucagon-like peptide 1 (GLP-1) receptor agonists. GLP-1 receptor agonists are primarily indicated for the treatment of type 2 diabetes to improve glycemic control by stimulating insulin secretion and inhibiting glucagon release. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.